NASDAQ NMS - GLOBAL MARKET · ORGO
-24.07% · -$0.5800 · Vol 4.9M
Market closed · last close 4:00 PM ET · price as of 19:48:31 ET
Organogenesis Holdings Inc

Organogenesis Holdings Inc

Biotechnology
$1.83
Card
Relationship Map

Veridion Score

BETALOW CONF · 5/6 factorsMethodology
ORGO
Organogenesis Holdings Inc
Fri Aug 7 · market closed · Markets closed · resumes Mon 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

54/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 5/6 factors with data · Fri Aug 7 · market closed · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is ORGO moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading ORGO catalysts
About Organogenesis Holdings Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2016
Employees
854
Country
US

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.75
Day high
$1.88
Day low
$1.54
Previous close
$2.41
52W high
$6.54
-72.02% from high
52W low
$1.54
6% of range
Market cap
$310.1M
P/E
88.50×
EPS
$-0.6000
Beta
0.61
Shares out
128.7M
Volume
4.9M
5.31× rel vol
Avg volume
914.4K
VWAP
$1.75
Price history computed in-house
1W
-22.78%
1M
-25.61%
3M
-22.78%
1Y
-59.82%
YTD
-64.67%
SMA 50 $2.43 · below
SMA 200 $3.41 · below
52W position 6%

ORGO overview

Veridion Score
54
5 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around ORGO.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading ORGO Form 4 filings
Public disclosures

Congress activity in ORGO

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for ORGO in the cached public ledger.

Federal contracts

ORGO contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ORGO in this window.
Lobbying spend

ORGO lobbying filings, year to date.

Registered lobbying filings matched to Organogenesis Holdings Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ORGO in this window.
Loading news for ORGO
Analyst ratings
Sovereign unlock shows live analyst consensus for ORGO.
Options
Sovereign unlock shows live options positioning for ORGO.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.